These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
617 related articles for article (PubMed ID: 22848149)
1. The effect of erythropoietin on normal and neoplastic cells. Elliott S; Sinclair AM Biologics; 2012; 6():163-89. PubMed ID: 22848149 [TBL] [Abstract][Full Text] [Related]
3. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors. Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826 [TBL] [Abstract][Full Text] [Related]
4. Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patients. Sinclair AM; Todd MD; Forsythe K; Knox SJ; Elliott S; Begley CG Cancer; 2007 Aug; 110(3):477-88. PubMed ID: 17582631 [TBL] [Abstract][Full Text] [Related]
5. The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression. Hedley BD; Allan AL; Xenocostas A Clin Cancer Res; 2011 Oct; 17(20):6373-80. PubMed ID: 21750199 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts. Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111 [TBL] [Abstract][Full Text] [Related]
8. Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation: possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome. Shimizu R; Komatsu N; Miura Y Exp Hematol; 1999 Feb; 27(2):229-33. PubMed ID: 10029161 [TBL] [Abstract][Full Text] [Related]
9. Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues. Liu W; Varier KM; Sample KM; Zacksenhaus E; Gajendran B; Ben-David Y Adv Exp Med Biol; 2020; 1223():17-30. PubMed ID: 32030683 [TBL] [Abstract][Full Text] [Related]
10. Effect of Tumor Necrosis Factor-Alpha on Erythropoietin and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients. Tanyong DI; Panichob P; Kheansaard W; Fucharoen S Turk J Haematol; 2015 Dec; 32(4):304-10. PubMed ID: 26376749 [TBL] [Abstract][Full Text] [Related]
11. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation. Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950 [TBL] [Abstract][Full Text] [Related]
12. Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Suzuki N; Ohneda O; Takahashi S; Higuchi M; Mukai HY; Nakahata T; Imagawa S; Yamamoto M Blood; 2002 Oct; 100(7):2279-88. PubMed ID: 12239135 [TBL] [Abstract][Full Text] [Related]
13. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology. Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin, erythropoiesis and beyond. Chateauvieux S; Grigorakaki C; Morceau F; Dicato M; Diederich M Biochem Pharmacol; 2011 Nov; 82(10):1291-303. PubMed ID: 21782802 [TBL] [Abstract][Full Text] [Related]
15. Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis. Okazaki T; Ebihara S; Asada M; Yamanda S; Niu K; Arai H Neoplasia; 2008 Sep; 10(9):932-9. PubMed ID: 18714393 [TBL] [Abstract][Full Text] [Related]
16. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts. Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer. Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814 [TBL] [Abstract][Full Text] [Related]
18. Lack of expression and function of erythropoietin receptors in the kidney. Elliott S; Busse L; Swift S; McCaffery I; Rossi J; Kassner P; Begley CG Nephrol Dial Transplant; 2012 Jul; 27(7):2733-45. PubMed ID: 22167585 [TBL] [Abstract][Full Text] [Related]
19. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin. Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043 [TBL] [Abstract][Full Text] [Related]
20. Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells. Sinclair AM; Coxon A; McCaffery I; Kaufman S; Paweletz K; Liu L; Busse L; Swift S; Elliott S; Begley CG Blood; 2010 May; 115(21):4264-72. PubMed ID: 20124513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]